Apimeds Pharmaceuticals US, Inc
APUSHealthcare|Biotechnology|US
$2.71
-0.03 (-0.92%)
Tangible Book / Share
$65.19
Cash / Share
$0.17
About
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Stock Price
-89.2%(1Y)
1M
-50.9%
3M
-36.1%
6M
-82.1%
YTD
-83.5%
1Y
-89.9%
3Y
-87.7%
5Y
-87.7%
Pipeline Summary
0 total trials0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
Key Facts
Market Cap$4.1M
Employees7 (+250% YoY)
CEOVinod Menon
IPO DateMay 9, 2025
Beta0.15
52-Week Range$1.51 – $59.7
Avg Volume2,715,687
ExchangeAMEX
Websitemindwavedao.com
Ownership
Float37.3%
Shares Outstanding1.5M
Recent Insider Trades
Chae SungjoonOTHER
Oct 1, 20260 shares
Sherb Eric MichaelOTHER
Dec 1, 20250 shares
Menon VinOTHER
Dec 1, 2025484,775 shares
Inscobee Inc.OTHER
May 12, 20240 shares
Weintraub BennettAWARD
Nov 11, 202510,000 shares @ $2.67
Peers
Recent News
IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.
Nov 3, 2026 · globenewswire.com
NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide
Oct 13, 2026 · globenewswire.com
MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure
Oct 9, 2026 · globenewswire.com
MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media
Sep 29, 2026 · globenewswire.com
Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?
Sep 24, 2026 · benzinga.com
Data last updated: Nov 9, 2026, 03:55 AM